Scientific Researcher
CurrentOur research focuses on translational cancer immunotherapy from the laboratory into the clinic and includes:1. The mechanisms of tumor-induced immune cell dysfunction, including the role of multiple inhibitory receptor pathways (PD-1, Tim-3, BTLA and TIGIT). 2. Novel combinatorial immunotherapies in cancer patients, including dual immune checkpoint blockades and intratumoral TLR9 agonist together with PD-1 blockade.3. Studies of the gut microbiome in cancer Immunotherapy.